As the physiological symptoms of septic arthritis worsened with greater MRSA bioburden, the mRNA expression of Slc2a1 and Slc16a3 increased, and expression levels slightly decreased over time, but still remained higher than normal (Fig 1 E and F). The gene discussed is SLC16A3; the disease is bacterial arthritis.